Medirom Healthcare Technologies Inc (MRM) — Capital Reinvestment Ratio

Latest as of March 2024: 2.86x

Medirom Healthcare Technologies Inc (MRM) has a Capital Reinvestment Ratio of 2.86x as of March 2024, meaning it reinvests 3% of its operating cash flow ($27.79 Million) in capital expenditures ($79.60 Million). See MRM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

2.86x
Capex / Operating Cash Flow

Operating Cash Flow

$27.79 Million
USD

Capital Expenditures

$79.60 Million
USD

Data as of

Mar 2024
Most recent filing

Medirom Healthcare Technologies Inc Capital Reinvestment Ratio (2018–2019)

This chart tracks Medirom Healthcare Technologies Inc's Capital Reinvestment Ratio across 2 annual periods.

Annual Capital Reinvestment Ratio for Medirom Healthcare Technologies Inc (2018–2019)

Year-by-year Capital Reinvestment Ratio for Medirom Healthcare Technologies Inc from 2018 to 2019. For live market cap and broader valuation context, see Medirom Healthcare Technologies Inc market capitalisation.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2019 0.94x $7.87 Million $7.41 Million ▲ +289.3%
2018 0.24x $141.87 Million $34.30 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow